TY - JOUR
T1 - 新型冠状病毒肺炎暴发期间阿拉伯海湾地区糖尿病患者和非糖尿病患者心理健康结果的决定因素
AU - Al-Sofiani, Mohammed E.
AU - Albunyan, Sarah
AU - Alguwaihes, Abdullah M.
AU - Kalyani, Rita R.
AU - Golden, Sherita Hill
AU - Alfadda, Assim
N1 - Funding Information:
The authors extend their appreciation to the Deputyship for Research & Innovation, ?Ministry of Education? in Saudi Arabia for funding this research work through the project no. (IFKSURG-2020-123). Author Contributions Mohammed Al-Sofiani developed the study proposal, designed the study questionnaire; collected, analyzed, and interpreted the data; and drafted the study manuscript. Sarah Albunyan helped with the data collection and data coding, drafted sections of the final manuscript, and revised the full manuscript. Abdullah Alguwaihes distributed the study questionnaire and provided critical revision of the manuscript. Rita Kalyani helped with writing the manuscript and provided critical revisions of the study and final manuscript. Sherita Golden helped with writing the manuscript and provided critical revisions of the study and final manuscript. Assim Alfadda helped with designing the study and provided critical revision of the manuscript for important intellectual content.
Funding Information:
The authors extend their appreciation to the Deputyship for Research & Innovation, “Ministry of Education” in Saudi Arabia for funding this research work through the project no. (IFKSURG‐2020‐123).
Publisher Copyright:
© 2020 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd
PY - 2021/4
Y1 - 2021/4
N2 - Aims: To determine the prevalence and factors associated with depression and anxiety among people with and without diabetes during the coronavirus disease 2019 (COVID-19) outbreak. Methods: A cross-sectional questionnaire-based study collecting demographic and mental health data from 2166 participants living in the Arab Gulf region (568 with diabetes, 1598 without diabetes). Depression and anxiety were assessed using the 9-item Patient Health Questionnaire and the 7-item Generalized Anxiety Disorder scale, respectively. Results: The prevalence of depression and anxiety symptoms were 61% and 45%, in people with diabetes (PWD) and 62% and 44%, respectively, in people without diabetes. PWD who have had their diabetes visit canceled by the clinic were more likely to report depression and anxiety symptoms than those without diabetes (odds ratio [95% confidence interval]: 1.37 [1.02, 1.84] and 1.37 [1.04, 1.80], for depression and anxiety; respectively). PWD who had no method of telecommunication with their health care providers (HCP) during the pandemic, PWD with A1C of ≥ 10%, women, employees (particularly HCPs), students, unmarried individuals, and those with lower income were more likely to report depression and/or anxiety symptoms (all P < 0.01). Fear of acquiring the coronavirus infection; running out of diabetes medications; or requiring hospitalization for hypoglycemia, hyperglycemia, or diabetic ketoacidosis; and lack of telecommunication with HCPs were all associated with significantly higher odds of having depression and anxiety symptoms among PWD. Conclusions: The remarkably high prevalence of depression and anxiety symptoms during the COVID-19 pandemic, particularly among subgroups of PWD, calls for urgent public health policies to address mental health during the pandemic and reestablish health care access for PWD.
AB - Aims: To determine the prevalence and factors associated with depression and anxiety among people with and without diabetes during the coronavirus disease 2019 (COVID-19) outbreak. Methods: A cross-sectional questionnaire-based study collecting demographic and mental health data from 2166 participants living in the Arab Gulf region (568 with diabetes, 1598 without diabetes). Depression and anxiety were assessed using the 9-item Patient Health Questionnaire and the 7-item Generalized Anxiety Disorder scale, respectively. Results: The prevalence of depression and anxiety symptoms were 61% and 45%, in people with diabetes (PWD) and 62% and 44%, respectively, in people without diabetes. PWD who have had their diabetes visit canceled by the clinic were more likely to report depression and anxiety symptoms than those without diabetes (odds ratio [95% confidence interval]: 1.37 [1.02, 1.84] and 1.37 [1.04, 1.80], for depression and anxiety; respectively). PWD who had no method of telecommunication with their health care providers (HCP) during the pandemic, PWD with A1C of ≥ 10%, women, employees (particularly HCPs), students, unmarried individuals, and those with lower income were more likely to report depression and/or anxiety symptoms (all P < 0.01). Fear of acquiring the coronavirus infection; running out of diabetes medications; or requiring hospitalization for hypoglycemia, hyperglycemia, or diabetic ketoacidosis; and lack of telecommunication with HCPs were all associated with significantly higher odds of having depression and anxiety symptoms among PWD. Conclusions: The remarkably high prevalence of depression and anxiety symptoms during the COVID-19 pandemic, particularly among subgroups of PWD, calls for urgent public health policies to address mental health during the pandemic and reestablish health care access for PWD.
KW - COVID-19
KW - anxiety
KW - depression
KW - diabetes
KW - mental health
UR - http://www.scopus.com/inward/record.url?scp=85099368794&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099368794&partnerID=8YFLogxK
U2 - 10.1111/1753-0407.13149
DO - 10.1111/1753-0407.13149
M3 - Article
C2 - 33351239
AN - SCOPUS:85099368794
VL - 13
SP - 339
EP - 352
JO - Journal of Diabetes
JF - Journal of Diabetes
SN - 1753-0393
IS - 4
ER -